Provider Resources

Amida Care Community Figures 2

Documents:

Amida Care Formulary
Provider Manual

Provider Modification Form

The purpose of the Provider Modification Form is to Communicate Name, Address, and Other Office Changes to Amida Care.

To ensure that Amida Care and our members have the most up-to-date information about your practice, we are pleased to introduce the updated Provider Modification Form.

When you are changing your practice name, address, phone numbers, e-mail, billing company, or other practice information, you only need to complete this single form and send it via email, fax, or US mail.

For questions about specific Amida Care policies or requirements, please contact us at: 1-800-556-0674

Important Reminder!

Communicable disease reporting and the Universal Reporting Form (URF):
NYCDOHMH disease surveillance is a cornerstone of overall health of all NYC residents. To that end, it is essential that all providers promptly report all communicable diseases and conditions as required by law on the NYCDOHMH Universal Reporting Form (URF) . For any questions or to report cases immediately, call the DOH Provider Access Line at 1-866-NYC-DOH1 or, after hours, the Poison Control Center at 1-800-222-1222.

Education

HEDIS and QARR Measures Quick Reference Guide 2017

HEDIS Behavioral Health Reference Guide 2017

Medical Record Review Standards and Criteria

Medscape.org for the latest continuing education activities, medical news, drug information, MEDLINE, and more

USDHHS National Guidelines for the Treatment of HIV, Clinical Trials and other health topics

Learn more about Amida Care’s work to advance treatment and cure of Hepatitis C:

New Hepatitis Drugs in a Medicaid Special Needs Population – A Preliminary Report

How a Medicaid HIV Special Needs Managed Care Plan in NYC Achieved Cost Savings and Successful Clinical Outcomes

A Medicaid Hepatitis C Prior Authorization Program Outcomes Evaluation

Websites:

New York State Department of Health AIDS Institute HIV Clinical Resource HIV guidelines
USDHHS HIV treatment, prevention, research, guidelines, clinical trials
New York State Department of Health
Office of the Inspector General